Whitehawk Therapeutics (WHWK) Asset Utilization Ratio (2018 - 2025)
Historic Asset Utilization Ratio for Whitehawk Therapeutics (WHWK) over the last 8 years, with Q3 2025 value amounting to 0.08.
- Whitehawk Therapeutics' Asset Utilization Ratio fell 6910.23% to 0.08 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08, marking a year-over-year decrease of 6910.23%. This contributed to the annual value of 0.26 for FY2024, which is 6663.59% up from last year.
- Latest data reveals that Whitehawk Therapeutics reported Asset Utilization Ratio of 0.08 as of Q3 2025, which was down 6910.23% from 0.1 recorded in Q2 2025.
- Over the past 5 years, Whitehawk Therapeutics' Asset Utilization Ratio peaked at 0.39 during Q2 2021, and registered a low of 0.0 during Q3 2021.
- Its 5-year average for Asset Utilization Ratio is 0.17, with a median of 0.15 in 2022.
- In the last 5 years, Whitehawk Therapeutics' Asset Utilization Ratio tumbled by 9893.21% in 2021 and then skyrocketed by 426650.44% in 2022.
- Whitehawk Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.09 in 2021, then decreased by 6.95% to 0.08 in 2022, then surged by 122.56% to 0.18 in 2023, then surged by 86.06% to 0.33 in 2024, then tumbled by 75.17% to 0.08 in 2025.
- Its Asset Utilization Ratio stands at 0.08 for Q3 2025, versus 0.1 for Q2 2025 and 0.18 for Q1 2025.